Patterns of prescription and adherence to European Association of Urology guidelines on androgen deprivation therapy in prostate cancer: An Italian multicentre cross-sectional analysis from the Choosing Treatment for Prostate Cancer (CHOICE) study

Autor: Pietro Gabriele, G Savoca, Roberto Bortolus, Arcangelo Pagliarulo, Vincenzo Ficarra, Alberto Del Nero, Umberto Ricardi, Giovanna Mantini, Sergio Serni, R. Tenaglia, Andrea Tubaro, Giancarlo Lay, Filiberto Zattoni, Giovanni Novella, Claudio Simeone, Ugo De Paula, Massimo Porena, Paola Pinnarò, Giorgio Carmignani, Giuseppe Morgia, Vincenzo Mirone, Rosario Leonardi, Maurizio Brausi, Paolo Gontero, Salvatore Siracusano, Fabio Trippa, Giorgio Ivan Russo, Giuseppe Mario Ludovico, Francesco Rocco, D.F. Randone, Giuseppe Vespasiani, Renzo Corvò, Carlo Terrone
Jazyk: angličtina
Rok vydání: 2016
Předmět:
Male
Time Factors
Cross-sectional study
medicine.medical_treatment
030232 urology & nephrology
androgen deprivation therapy
Settore MED/24 - Urologia
Androgen deprivation therapy
Prostate cancer
0302 clinical medicine
European Association of Urology
adherence
guidelines
prostate cancer
Aged
Aged
80 and over

Androgen Antagonists
Antineoplastic Agents
Hormonal

Combined Modality Therapy
Cross-Sectional Studies
Humans
Italy
Neoplasm Recurrence
Local

Patient Selection
Practice Guidelines as Topic
Prescriptions
Prostate-Specific Antigen
Prostatic Neoplasms
Urology
Guideline Adherence
80 and over
Settore MED/36 - DIAGNOSTICA PER IMMAGINI E RADIOTERAPIA
Prostatectomy
Prostate-specific antigen
Local
030220 oncology & carcinogenesis
Cohort
medicine.medical_specialty
Antineoplastic Agents
03 medical and health sciences
medicine
Medical prescription
Hormonal
business.industry
Neoplasm Recurrence
Odds ratio
adherence
androgen deprivation therapy
European Association of Urology
guidelines
prostate cancer
Urology

medicine.disease
business
Popis: Objective To evaluate both the patterns of prescription of androgen deprivation therapy (ADT) in patients with prostate cancer (PCa) and the adherence to European Association of Urology (EAU) guidelines for ADT prescription. Methods The Choosing Treatment for Prostate Cancer (CHOICE) study was an Italian multicentre cross-sectional study conducted between December 2010 and January 2012. A total of 1 386 patients, treated with ADT for PCa (first prescription or renewal of ADT), were selected. With regard to the EAU guidelines on ADT, the cohort was categorized into discordant ADT (Group A) and concordant ADT (Group B). Results The final cohort included 1 075 patients with a geographical distribution including North Italy (n = 627, 58.3%), Central Italy (n = 233, 21.7%) and South Italy (n = 215, 20.0%). In the category of patients treated with primary ADT, a total of 125 patients (56.3%) were classified as low risk according to D'Amico classification. With regard to the EAU guidelines, 285 (26.51%) and 790 patients (73.49%) were classified as discordant (Group A) and concordant (Group B), respectively. In Group A, patients were more likely to receive primary ADT (57.5%, 164/285 patients) than radical prostatectomy (RP; 30.9%, 88/285 patients), radiation therapy (RT; 6.7%, 19/285 patients) or RP + RT (17.7%, 14/285 patients; P < 0.01). Multivariate logistic regression analysis, adjusted for clinical and pathological variables, showed that patients from Central Italy (odds ratio [OR] 2.86; P < 0.05) and South Italy (OR 2.65; P < 0.05) were more likely to receive discordant ADT. Conclusion EAU guideline adherence for ADT was low in Italy and was influenced by geographic area. Healthcare providers and urologists should consider these results in order to quantify the inadequate use of ADT and to set policy strategies to overcome this risk.
Databáze: OpenAIRE